Division of Drug Discovery Research, Faculty of Advanced Life Science and Graduate School of Life Science, Hokkaido University, Kita-ku, Sapporo, Japan.
Department of Biochemistry, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
PLoS One. 2018 Dec 28;13(12):e0209515. doi: 10.1371/journal.pone.0209515. eCollection 2018.
Most glycomics studies have focused on understanding disease mechanisms and proposing serum markers for various diseases, yet the influence of ethnic variation on the identified glyco-biomarker remains poorly addressed. This study aimed to investigate the inter-ethnic serum N-glycan variation among US origin control, Japanese, Indian, and Ethiopian healthy volunteers.
Human serum from 54 healthy subjects of various ethnicity and 11 Japanese hepatocellular carcinoma (HCC) patients were included in the study. We employed a comprehensive glycoblotting-assisted MALDI-TOF/MS-based quantitative analysis of serum N-glycome and fluorescence HPLC-based quantification of sialic acid species. Data representing serum N-glycan or sialic acid levels were compared among the ethnic groups using SPSS software.
Total of 51 N-glycans released from whole serum glycoproteins could be reproducibly quantified within which 33 glycoforms were detected in all ethnicities. The remaining N-glycans were detected weakly but exclusively either in the Ethiopians (13 glycans) or in all the other ethnic groups (5 glycans). Highest abundance (p < 0.001) of high mannose, core-fucosylated, hyperbranched/hypersialylated N-glycans was demonstrated in Ethiopians. In contrast, only one glycan (m/z 2118) significantly differed among all ethnicities being highest in Indians and lowest in Ethiopians. Glycan abundance trend in Ethiopians was generally close to that of Japanese HCC patients. Glycotyping analysis further revealed ethnic-based disparities mainly in the branched and sialylated structures. Surprisingly, some of the glycoforms greatly elevated in the Ethiopian subjects have been identified as serum biomarkers of various cancers. Sialic acid level was significantly increased primarily in Ethiopians, compared to the other ethnicities.
The study revealed ethnic-specific differences in healthy human serum N-glycome with highest abundance of most glycoforms in the Ethiopian ethnicity. The results strongly emphasized the need to consider ethnicity matching for accurate glyco-biomarker identification. Further large-scale study employing various ethnic compositions is needed to verify the current result.
大多数糖组学研究都集中在了解疾病机制和提出各种疾病的血清标志物上,但种族差异对鉴定糖生物标志物的影响仍未得到充分解决。本研究旨在调查美国起源的对照组、日本、印度和埃塞俄比亚健康志愿者之间的血清 N-聚糖的种族间差异。
本研究纳入了 54 名不同种族的健康受试者和 11 名日本肝细胞癌(HCC)患者的血清。我们采用了基于 MALDI-TOF/MS 的综合糖谱辅助定量分析和荧光 HPLC 定量分析血清唾液酸种类,对血清 N-聚糖和唾液酸水平进行了研究。使用 SPSS 软件比较了不同种族之间的血清 N-聚糖或唾液酸水平。
从全血清糖蛋白中释放的 51 种 N-聚糖可以在所有种族中重复定量,其中 33 种糖型在所有种族中都有检测到。其余的 N-聚糖在埃塞俄比亚人(13 种聚糖)或所有其他种族(5 种聚糖)中检测到较弱,但却是特异性的。高甘露糖、核心岩藻糖基化、高度分支/高唾液酸化的 N-聚糖丰度最高(p<0.001)。相反,只有一种糖(m/z 2118)在所有种族中都有显著差异,在印度人中最高,在埃塞俄比亚人中最低。埃塞俄比亚人的聚糖丰度趋势总体上与日本 HCC 患者相似。糖型分析进一步显示,种族之间的差异主要在分支和唾液酸化结构上。令人惊讶的是,一些在埃塞俄比亚受试者中显著升高的糖型已被鉴定为各种癌症的血清生物标志物。与其他种族相比,唾液酸水平在埃塞俄比亚人显著升高。
本研究揭示了健康人类血清 N-聚糖的种族特异性差异,其中埃塞俄比亚种族的大多数糖型丰度最高。结果强烈强调了为准确鉴定糖生物标志物需要考虑种族匹配。需要进行更大规模的研究,采用各种种族组成,以验证当前的结果。